Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. | SVP,Clinical & Medical Affairs | Employee Stock Option (right to buy) | 400K | Mar 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 10, 2023 | SVP,Clinical & Medical Affairs |
LCTX | Lineage Cell Therapeutics, Inc. | Feb 11, 2023 | 3 | -$7.17K | 4 | Feb 14, 2023 | SVP,Clinical & Medical Affairs |
LCTX | Lineage Cell Therapeutics, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 11, 2022 | SVP,Clinical & Medical Affairs |
LCTX | Lineage Cell Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | SVP,Clinical & Medical Affairs |
LCTX | Lineage Cell Therapeutics, Inc. | Dec 28, 2021 | 11 | -$596K | 4 | Dec 30, 2021 | SVP,Clinical & Medical Affairs |